HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Matozaki Selected Research

Takashi Matozaki Research Topics

Disease

11Neoplasms (Cancer)
04/2022 - 11/2011
4Colitis
01/2020 - 12/2010
3Stomach Neoplasms (Stomach Cancer)
05/2010 - 09/2002
2Carcinogenesis
01/2021 - 03/2009
2Neoplasm Metastasis (Metastasis)
01/2020 - 05/2007
2Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 04/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 08/2015
2Breast Neoplasms (Breast Cancer)
01/2017 - 11/2011
2Insulin Resistance
09/2014 - 11/2008
2Hypothermia
11/2012 - 06/2012
2Contact Dermatitis (Eczema, Contact)
11/2008 - 04/2006
1Nephritis
07/2020
1Atherosclerosis
01/2020
1Infections
01/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020
1Wallerian Degeneration
12/2019
1Demyelinating Diseases (Demyelinating Disease)
01/2019
1Colonic Neoplasms (Colon Cancer)
11/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2018
1Scrapie
01/2017
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2017
1Hyperplasia
11/2016
1Hyperlipidemias (Hyperlipidemia)
09/2014
1Obesity
09/2014
1Inflammation (Inflammations)
01/2014
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
09/2013
1Albuminuria
09/2013
1Glomerulonephritis
06/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2012
1Splenomegaly
06/2012
1Starvation
06/2012
1Brain Diseases (Brain Disorder)
12/2011
1Alzheimer Disease (Alzheimer's Disease)
12/2009
1Bone Resorption
12/2009
1Glucose Intolerance
11/2008
1Arthritis (Polyarthritis)
07/2008
1Rheumatoid Arthritis
07/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2007

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2002
6AntibodiesIBA
01/2020 - 06/2003
5Protein Tyrosine PhosphatasesIBA
08/2015 - 09/2002
5Tyrosine (L-Tyrosine)FDA Link
06/2012 - 09/2002
3src-Family KinasesIBA
01/2021 - 11/2016
3Peptides (Polypeptides)IBA
01/2020 - 07/2007
2Rituximab (Mabthera)FDA Link
01/2022 - 05/2018
2Mechanistic Target of Rapamycin Complex 1IBA
01/2020 - 04/2019
2ChemokinesIBA
01/2020 - 08/2015
2CytokinesIBA
01/2020 - 08/2015
2Monoclonal AntibodiesIBA
11/2018 - 11/2011
2Fc Receptors (Fc Receptor)IBA
01/2018 - 04/2004
1AntigensIBA
04/2022
1chenodeoxycholate sulfate conjugate (CDCS)IBA
04/2022
1Collagenases (Collagenase)FDA Link
07/2020
1Explosive Agents (Explosives)IBA
01/2020
1Dextran SulfateIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1CuprizoneIBA
01/2019
1cytidylyl-(3'-5')-cytidine (CpC)IBA
11/2018
1Biological ProductsIBA
08/2018
1Recombinant ProteinsIBA
08/2018
1Neoplasm Antigens (Tumor Antigens)IBA
05/2018
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2018
1Dextrans (Dextran)FDA Link
01/2018
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2017
1Prion ProteinsIBA
01/2017
1PrionsIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1InterleukinsIBA
08/2015
1LipidsIBA
09/2014
1Leptin ReceptorsIBA
09/2014
1LeptinIBA
09/2014
1AMP-Activated Protein KinasesIBA
09/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2012
1ElementsIBA
11/2012
1AutoantibodiesIBA
06/2012
1PicrotoxinIBA
06/2012
1Ethanol (Ethyl Alcohol)IBA
06/2012
1Trastuzumab (Herceptin)FDA Link
11/2011
1Interleukin-17 (Interleukin 17)IBA
12/2010
1Interleukin-10 (Interleukin 10)IBA
12/2010
1Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
05/2010
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
05/2010
1Amyloid (Amyloid Fibrils)IBA
12/2009
1LigandsIBA
11/2008
1DinitrofluorobenzeneIBA
11/2008
1Yohimbine (Yocon)IBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1Insulin (Novolin)FDA Link
11/2008
1Collagen Type II (Type II Collagen)IBA
07/2008
1Myelin-Oligodendrocyte GlycoproteinIBA
07/2007
1alpha-galactosylceramideIBA
05/2007
1Pertussis ToxinIBA
04/2006
1SHPS-1-Fc fusion proteinIBA
04/2006

Therapy/Procedure

6Immunotherapy
01/2022 - 12/2017
5Therapeutics
01/2021 - 11/2011
1Transplantation
01/2020
1Induced Hypothermia
06/2012
1Anesthesia
06/2012
1Ligation
04/2006